These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Drug resistance mediated by ABC transporters]. Yoshikawa M; Ito A; Ishikawa T; Ikegami Y Gan To Kagaku Ryoho; 2004 Jan; 31(1):1-6. PubMed ID: 14750312 [TBL] [Abstract][Full Text] [Related]
26. Mouse ATP-Binding Cassette (ABC) Transporters Conferring Multi-Drug Resistance. Li S; Zhang W; Yin X; Xing S; Xie HQ; Cao Z; Zhao B Anticancer Agents Med Chem; 2015; 15(4):423-32. PubMed ID: 25929575 [TBL] [Abstract][Full Text] [Related]
27. In vitro and in vivo evaluation of WK-X-34, a novel inhibitor of P-glycoprotein and BCRP, using radio imaging techniques. Jekerle V; Klinkhammer W; Scollard DA; Breitbach K; Reilly RM; Piquette-Miller M; Wiese M Int J Cancer; 2006 Jul; 119(2):414-22. PubMed ID: 16646006 [TBL] [Abstract][Full Text] [Related]
28. Multidrug resistance/P-glycoprotein and breast cancer: review and meta-analysis. Clarke R; Leonessa F; Trock B Semin Oncol; 2005 Dec; 32(6 Suppl 7):S9-15. PubMed ID: 16360717 [TBL] [Abstract][Full Text] [Related]
29. Clinical management of recurrent breast cancer: development of multidrug resistance (MDR) and strategies to circumvent it. Hait WN; Yang JM Semin Oncol; 2005 Dec; 32(6 Suppl 7):S16-21. PubMed ID: 16360718 [TBL] [Abstract][Full Text] [Related]
30. [A new method for the intravital assessment of the functional activity of the membrane transporters performing the efflux of antitumor preparations from the cells of solid tumor specimens]. Bogush TA; Smirnova GB; Bogush EA; Robert J Antibiot Khimioter; 1999; 44(2):19-24. PubMed ID: 10202553 [TBL] [Abstract][Full Text] [Related]
32. Strategies for overcoming ABC-transporters-mediated multidrug resistance (MDR) of tumor cells. Borowski E; Bontemps-Gracz MM; Piwkowska A Acta Biochim Pol; 2005; 52(3):609-27. PubMed ID: 16175236 [TBL] [Abstract][Full Text] [Related]
33. Tyrosine kinase inhibitors influence ABCG2 expression in EGFR-positive MDCK BCRP cells via the PI3K/Akt signaling pathway. Pick A; Wiese M ChemMedChem; 2012 Apr; 7(4):650-62. PubMed ID: 22354538 [TBL] [Abstract][Full Text] [Related]
34. Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its expression. Nobili S; Landini I; Mazzei T; Mini E Med Res Rev; 2012 Nov; 32(6):1220-62. PubMed ID: 21374643 [TBL] [Abstract][Full Text] [Related]
35. Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2). Pedersen JM; Matsson P; Bergström CA; Norinder U; Hoogstraate J; Artursson P J Med Chem; 2008 Jun; 51(11):3275-87. PubMed ID: 18457386 [TBL] [Abstract][Full Text] [Related]
36. High-throughput flow cytometry to detect selective inhibitors of ABCB1, ABCC1, and ABCG2 transporters. Ivnitski-Steele I; Larson RS; Lovato DM; Khawaja HM; Winter SS; Oprea TI; Sklar LA; Edwards BS Assay Drug Dev Technol; 2008 Apr; 6(2):263-76. PubMed ID: 18205550 [TBL] [Abstract][Full Text] [Related]
37. Gefitinib modulates the function of multiple ATP-binding cassette transporters in vivo. Leggas M; Panetta JC; Zhuang Y; Schuetz JD; Johnston B; Bai F; Sorrentino B; Zhou S; Houghton PJ; Stewart CF Cancer Res; 2006 May; 66(9):4802-7. PubMed ID: 16651435 [TBL] [Abstract][Full Text] [Related]
39. Expression and activity of the efflux transporters ABCB1, ABCC2 and ABCG2 in the human colorectal carcinoma cell line LS513. Salphati L; Plise EG; Li G Eur J Pharm Sci; 2009 Jun; 37(3-4):463-8. PubMed ID: 19491037 [TBL] [Abstract][Full Text] [Related]
40. Potent and selective inhibitors of breast cancer resistance protein (ABCG2) derived from the p-glycoprotein (ABCB1) modulator tariquidar. Kühnle M; Egger M; Müller C; Mahringer A; Bernhardt G; Fricker G; König B; Buschauer A J Med Chem; 2009 Feb; 52(4):1190-7. PubMed ID: 19170519 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]